1. ERCC1 mutations impede DNA damage repair and cause liver and kidney dysfunction in patients.
- Author
-
Apelt K, White SM, Kim HS, Yeo JE, Kragten A, Wondergem AP, Rooimans MA, González-Prieto R, Wiegant WW, Lunke S, Flanagan D, Pantaleo S, Quinlan C, Hardikar W, van Attikum H, Vertegaal ACO, Wilson BT, Wolthuis RMF, Schärer OD, and Luijsterburg MS
- Subjects
- Alleles, Amino Acid Substitution, Base Sequence, Cell Line, Cytoplasm metabolism, DNA Breaks, Double-Stranded, DNA-Binding Proteins deficiency, DNA-Binding Proteins metabolism, Endonucleases deficiency, Fibroblasts metabolism, Fibroblasts pathology, Humans, Light, Liver pathology, Liver physiopathology, Mutant Proteins metabolism, Mutation, Missense genetics, Protein Stability, Siblings, DNA Damage genetics, DNA Repair genetics, DNA-Binding Proteins genetics, Endonucleases genetics, Kidney pathology, Kidney physiopathology, Mutation genetics
- Abstract
ERCC1-XPF is a multifunctional endonuclease involved in nucleotide excision repair (NER), interstrand cross-link (ICL) repair, and DNA double-strand break (DSB) repair. Only two patients with bi-allelic ERCC1 mutations have been reported, both of whom had features of Cockayne syndrome and died in infancy. Here, we describe two siblings with bi-allelic ERCC1 mutations in their teenage years. Genomic sequencing identified a deletion and a missense variant (R156W) within ERCC1 that disrupts a salt bridge below the XPA-binding pocket. Patient-derived fibroblasts and knock-in epithelial cells carrying the R156W substitution show dramatically reduced protein levels of ERCC1 and XPF. Moreover, mutant ERCC1 weakly interacts with NER and ICL repair proteins, resulting in diminished recruitment to DNA damage. Consequently, patient cells show strongly reduced NER activity and increased chromosome breakage induced by DNA cross-linkers, while DSB repair was relatively normal. We report a new case of ERCC1 deficiency that severely affects NER and considerably impacts ICL repair, which together result in a unique phenotype combining short stature, photosensitivity, and progressive liver and kidney dysfunction., Competing Interests: Disclosures: The authors declare no competing interests exist., (© 2020 Crown copyright. The government of Australia, Canada, or the UK ("the Crown") owns the copyright interests of authors who are government employees. The Crown Copyright is not transferable.)
- Published
- 2021
- Full Text
- View/download PDF